Collagen-Based Therapeutic Delivery Systems

Professor Harbin's new patent introduces a fresh approach to collagen-based therapeutic delivery systems. These systems are designed to support cell growth and help cells integrate with surrounding tissue, creating a strong framework for cell infiltration. One of the standout features of this technology is its ability to deliver agents that promote blood vessel growth at the site of implantation, which is key for the success of tissue grafts.

The collagen-fibril matrices can be molded into various shapes and sizes, making them highly adaptable for both research and clinical applications. They’re perfect for creating complex tissue and organ constructs, especially those that need vascularization to restore damaged or dysfunctional organs. These systems can also be used in vitro for drug discovery, chemical toxicity testing, and developing tissue-engineered medical products.

A Legacy of Innovation

This patent is just one more piece in Professor Harbin’s impressive portfolio of innovations. Her work has not only pushed the boundaries of biomedical engineering but has also led to the creation of her startup company, GeniPhys. GeniPhys focuses on developing standardized, tunable collagen polymers called Collymers, which are used in both research and medical fields.

Over the years, Professor Harbin has earned multiple accolades, including being named a Fellow of the American Institute for Medical and Biological Engineering (AIMBE) and the National Academy of Inventors. Her research continues to inspire future biomedical engineers at Purdue.

The Weldon School of Biomedical Engineering is proud to support Professor Harbin's groundbreaking work and looks forward to seeing the continued impact of her innovations on the field and patient care.

The Purdue Innovates Office of Technology Commercialization operates one of the most comprehensive technology transfer programs among leading research universities in the U.S. Services provided by this office support the economic development initiatives of Purdue University and benefit the university’s academic activities through commercializing, licensing and protecting Purdue intellectual property. In fiscal year 2024, the office reported 145 deals finalized with 224 technologies signed, 466 invention disclosures received and 290 U.S. and international patents received. The office is managed by the Purdue Research Foundation, which received the 2019 Innovation and Economic Prosperity Universities Award for Place from the Association of Public and Land-grant Universities. In 2020, IPWatchdog Institute ranked Purdue third nationally in startup creation and in the top 20 for patents. The Purdue Research Foundation is a private, nonprofit foundation created to advance the mission of Purdue University. Contact otcip@prf.org for more information.